Interest Expense of MADRIGAL PHARMACEUTICALS, INC. from 31 Dec 2015 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
MADRIGAL PHARMACEUTICALS, INC. quarterly and annual Interest Expense in USD history and change rate from 31 Dec 2015 to 31 Mar 2025.
  • MADRIGAL PHARMACEUTICALS, INC. Interest Expense for the quarter ending 31 Mar 2025 was $3,297,000, a 14% decline year-over-year.
  • MADRIGAL PHARMACEUTICALS, INC. annual Interest Expense for 2023 was $12,712,000, a 221% increase from 2022.
  • MADRIGAL PHARMACEUTICALS, INC. annual Interest Expense for 2022 was $3,964,000.
  • MADRIGAL PHARMACEUTICALS, INC. annual Interest Expense for 2021 was $0.
Source SEC data
View on sec.gov
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

MADRIGAL PHARMACEUTICALS, INC. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $3,297,000 -$541,000 -14% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q3 2024 $15,144,000 $3,679,000 +$175,000 +5% 01 Jul 2024 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $14,969,000 $3,656,000 +$755,000 +26% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $14,214,000 $3,838,000 +$1,502,000 +64% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 $12,712,000 $3,971,000 +$2,289,000 +136% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2024 2023 FY
Q3 2023 $10,423,000 $3,504,000 +$2,002,000 +133% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024 2024 Q3
Q2 2023 $8,421,000 $2,901,000 +$2,121,000 +272% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $6,300,000 $2,336,000 +$2,336,000 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $3,964,000 $1,682,000 +$1,682,000 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $2,282,000 $1,502,000 +$1,502,000 01 Jul 2022 30 Sep 2022 10-K 28 Feb 2024 2023 FY
Q2 2022 $780,000 $780,000 +$780,000 01 Apr 2022 30 Jun 2022 10-K 28 Feb 2024 2023 FY
Q1 2022 $0 $0 $0 01 Jan 2022 31 Mar 2022 10-K 28 Feb 2024 2023 FY
Q4 2021 $0 $0 01 Oct 2021 31 Dec 2021 10-K/A 03 Mar 2023 2022 FY
Q3 2021 $0 01 Jul 2021 30 Sep 2021 10-K/A 03 Mar 2023 2022 FY
Q2 2021 $0 01 Apr 2021 30 Jun 2021 10-K/A 03 Mar 2023 2022 FY
Q1 2021 $0 01 Jan 2021 31 Mar 2021 10-K/A 03 Mar 2023 2022 FY
Q2 2016 $238,000 01 Apr 2016 30 Jun 2016 10-Q 10 Aug 2017 2017 Q2
Q1 2016 $975,000 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017 2017 Q1

MADRIGAL PHARMACEUTICALS, INC. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $12,712,000 +$8,748,000 +221% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2024 2023 FY
2022 $3,964,000 +$3,964,000 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2024 2023 FY
2021 $0 $0 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $0 01 Jan 2020 31 Dec 2020 10-K/A 03 Mar 2023 2022 FY
2016 $1,213,000 -$2,398,931 -66% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $3,611,931 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.